相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register
James B. Galloway et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study
Michael E. Weinblatt et al.
ARTHRITIS AND RHEUMATISM (2013)
Risk of infections in rheumatoid arthritis patients switching from anti-TNF agents to rituximab, abatacept, or another anti-TNF agent, a retrospective administrative claims analysis
Stephen S. Johnston et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2013)
Comparative safety of infliximab and etanercept on the risk of serious infections: does the association vary by patient characteristics?
Sengwee Toh et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)
The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents
Jeffrey R. Curtis et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis
Karen Au et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?
A. Strangfeld et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Initiation of Tumor Necrosis Factor-α Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune Diseases
Carlos G. Grijalva et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Associations of disease activity and treatments with mortality in men with rheumatoid arthritis: results from the VARA registry
Ted R. Mikuls et al.
RHEUMATOLOGY (2011)
A Comparison of Patient Characteristics and Outcomes in Selected European and US Rheumatoid Arthritis Registries
Jeffrey R. Curtis et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)
Serious infections during anti-TNF alpha treatment in rheumatoid arthritis patients
Ennio Giulio Favalli et al.
AUTOIMMUNITY REVIEWS (2009)
Administrative codes combined with medical records based criteria accurately identified bacterial infections among rheumatoid arthritis patients
Nivedita M. Patkar et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate
M. Schiff et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists
Johan Askling et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Serious infection following anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis -: Lessons from interpreting data from observational studies
W. G. Dixon et al.
ARTHRITIS AND RHEUMATISM (2007)
Anti-tumor necrosis factor a therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis
Sebastian Schneeweiss et al.
ARTHRITIS AND RHEUMATISM (2007)
Veteran's affairs hospital discharge databases coded serious bacterial infections accurately
Sebastian Schneeweiss et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2007)
Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonists
Jeffrey R. Curtis et al.
ARTHRITIS AND RHEUMATISM (2007)
Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor α antagonists and disease-modifying antirheumatic drugs
J. R. Curtis et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy - Results from the British Society for Rheumatology Biologics Register
W. G. Dixon et al.
ARTHRITIS AND RHEUMATISM (2006)
Infections in patients with rheumatoid arthritis treated with biologic agents
J Listing et al.
ARTHRITIS AND RHEUMATISM (2005)
Measurement in veterans affairs health services research: Veterans as a special population
RO Morgan et al.
HEALTH SERVICES RESEARCH (2005)
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score
D Aletaha et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Accuracy of veterans administration databases for a diagnosis of rheumatoid arthritis
JA Singh et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)
Evaluating medication effects outside of clinical trials: New-user designs
WA Ray
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Predictors of infection in rheumatoid arthritis
MF Doran et al.
ARTHRITIS AND RHEUMATISM (2002)
分享论文
